BioScrip to Present at Bank of America Merrill Lynch Leveraged Finance Conference

ELMSFORD, N.Y.--(BUSINESS WIRE)-- BioScrip (NASDAQ: BIOS) today announced that the Company will present at the Bank of America Merrill Lynch Leveraged Finance Conference to be held Wednesday, November 30 - Friday, December 2, 2011 at the Loews Royal Pacific Resort at Universal Orlando® in Orlando, Florida.

Richard M. Smith, President and Chief Executive Officer, and MJ Graves, interim Chief Financial Officer and Treasurer, will present on Wednesday, November 30, 2011 at 4 p.m. Eastern Standard Time. The presentation will also be available via a live audio webcast at the following link:

Following each presentation, a replay will be available through BioScrip's website at under the "Investors" section and will remain available for two weeks after the actual presentation date.

About BioScrip

BioScrip, Inc. ( (Nasdaq: BIOS) is a national provider of specialty pharmacy and home health services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivery of cost-effective access to prescription medications and home health services. Our services are designed to improve clinical outcomes with chronic and acute healthcare conditions while controlling overall healthcare costs.


In-Site Communications, Inc.
Lisa Wilson, 212-759-3929
Joele Frank, Wilkinson Brimmer Katcher
Meaghan Repko or Bryan Darrow, 212-355-4449

KEYWORDS:   United States  North America  Florida  New York

INDUSTRY KEYWORDS:   Health  Hospitals  Pharmaceutical  Professional Services  Finance  General Health  Managed Care